Form 8-K - Current report:
SEC Accession No. 0001683168-25-004669
Filing Date
2025-06-20
Accepted
2025-06-20 17:07:20
Documents
13
Period of Report
2025-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT aclarion_8k.htm   iXBRL 8-K 32230
  Complete submission text file 0001683168-25-004669.txt   249081

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE acon-20250616.xsd EX-101.SCH 3787
3 XBRL DEFINITION FILE acon-20250616_def.xml EX-101.DEF 30054
4 XBRL LABEL FILE acon-20250616_lab.xml EX-101.LAB 36764
5 XBRL PRESENTATION FILE acon-20250616_pre.xml EX-101.PRE 27077
15 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_8k_htm.xml XML 5794
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 251062238
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)